Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VWA1 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | SLC29A2 | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
mRNA | PXK | CCLE | pan-cancer | AAC | -0.22 | 0.0001 |
mRNA | LIPG | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | KLF2 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
mRNA | SERGEF | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | CTSH | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | GKAP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | DPYSL3 | CCLE | pan-cancer | AAC | -0.21 | 0.0001 |
mRNA | PRRG4 | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |